References
- Barker, P.A. (2004). p75NTR is positively promiscuous: novel partners and new insights. Neuron 42, 529-533. https://doi.org/10.1016/j.neuron.2004.04.001
- Freije, W.A., Castro-Vargas, F.E., Fang, Z., Horvath, S., Cloughesy, T., Liau, L.M., Mischel, P.S., and Nelson, S.F. (2004). Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64, 6503-6510. https://doi.org/10.1158/0008-5472.CAN-04-0452
- Hopkins-Donaldson, S., Ziegler, A., Kurtz, S., Bigosch, C., Kandioler, D., Ludwig, C., Zangemeister-Wittke, U., and Stahel, R. (2003). Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ. 10, 356-364. https://doi.org/10.1038/sj.cdd.4401157
- Hwang, S.J., Lee, H.W., Kim, H.R., Song, H.J., Lee, D.H., Lee, H., Shin, C.H., Joung, J.G., Kim, D.H., Joo, K.M., et al. (2015). Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Oncotarget 6, 20434-20448. https://doi.org/10.18632/oncotarget.3886
- Hwang, S.J., Lee, H.W., Kim, H.R., Lee, H., Shin, C.H., Yun, S.I., Lee, D.H., Kim, D.H., Kim, K.K., Joo, K.M., et al. (2016). Ubiquitin-specific protease 4 controls metastatic potential through beta-catenin stabilization in brain metastatic lung adenocarcinoma. Sci. Rep. 6, 21596. https://doi.org/10.1038/srep21596
- Jin, H., Pan, Y., Zhao, L., Zhai, H., Li, X., Sun, L., He, L., Chen, Y., Hong, L., Du, Y., et al. (2007). p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells. Neoplasia 9, 471-478. https://doi.org/10.1593/neo.07175
- Johnston, A.L., Lun, X., Rahn, J.J., Liacini, A., Wang, L., Hamilton, M.G., Parney, I.F., Hempstead, B.L., Robbins, S.M., Forsyth, P.A., et al. (2007). The p75 neurotrophin receptor is a central regulator of glioma invasion. PLoS Biol. 5, e212. https://doi.org/10.1371/journal.pbio.0050212
- Lee, W.S., Kwon, J., Yun, D.H., Lee, Y.N., Woo, E.Y., Park, M.J., Lee, J.S., Han, Y.H., and Bae, I.H. (2014). Specificity protein 1 expression contributes to Bcl-w-induced aggressiveness in glioblastoma multiforme. Mol. Cells 37, 17-23. https://doi.org/10.14348/molcells.2014.2161
- Lee, H., Park, S., Kang, Y.S., and Park, S. (2015). EphA receptors form a complex with caspase-8 to induce apoptotic cell death. Mol. Cells 38, 349-355. https://doi.org/10.14348/molcells.2015.2279
- Lee, H., Hwang, S.J., Kim, H.R., Shin, C.H., Choi, K.H., Joung, J.G., and Kim, H.H. (2016). Neurofibromatosis 2 (NF2) controls the invasiveness of glioblastoma through YAP-dependent expression of CYR61/CCN1 and miR-296-3p. Biochim. Biophys. Acta 1859, 599-611. https://doi.org/10.1016/j.bbagrm.2016.02.010
- Li, C., Egloff, A.M., Sen, M., Grandis, J.R., and Johnson, D.E. (2014). Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth. Mol. Oncol. 8, 1220-1230. https://doi.org/10.1016/j.molonc.2014.03.018
- Liang, Y., Diehn, M., Watson, N., Bollen, A.W., Aldape, K.D., Nicholas, M.K., Lamborn, K.R., Berger, M.S., Botstein, D., Brown, P.O., et al. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc. Natl. Acad. Sci. USA 102, 5814-5819. https://doi.org/10.1073/pnas.0402870102
- Marchetti, D., Aucoin, R., Blust, J., Murry, B., and Greiter-Wilke, A. (2004). p75 neurotrophin receptor functions as a survival receptor in brain-metastatic melanoma cells. J. Cell. Biochem. 91, 206-215. https://doi.org/10.1002/jcb.10649
- Menter, D.G., Herrmann, J.L., Marchetti, D., and Nicolson, G.L. (1994). Involvement of neurotrophins and growth factors in brain metastasis formation. Invasion Metastasis 14, 372-384.
- Moore, L.M., and Zhang, W. (2010). Targeting miR-21 in glioma: a small RNA with big potential. Exp. Opin. Ther. Targets 14, 1247-1257. https://doi.org/10.1517/14728222.2010.527334
- Oberst, A., and Green, D.R. (2011). It cuts both ways: reconciling the dual roles of caspase 8 in cell death and survival. Nat. Rev. Mol. Cell Biol. 12, 757-763. https://doi.org/10.1038/nrm3214
- Ohgaki, H., and Kleihues, P. (2007). Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 170, 1445-1453. https://doi.org/10.2353/ajpath.2007.070011
- Omuro, A., and DeAngelis, L.M. (2013). Glioblastoma and other malignant gliomas: a clinical review. Jama 310, 1842-1850. https://doi.org/10.1001/jama.2013.280319
- Pingoud-Meier, C., Lang, D., Janss, A.J., Rorke, L.B., Phillips, P.C., Shalaby, T., and Grotzer, M.A. (2003). Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin. Cancer Res. 9, 6401-6409.
- Quann, E.J., Khwaja, F., and Djakiew, D. (2007). The p38 MAPK pathway mediates aryl propionic acid induced messenger rna stability of p75 NTR in prostate cancer cells. Cancer Res. 67, 11402-11410. https://doi.org/10.1158/0008-5472.CAN-07-1792
- Reichardt, L.F. (2006). Neurotrophin-regulated signalling pathways. Philosophical transactions of the Royal Society of London. Series B, Biol. Sci. 361, 1545-1564.
- Sachs, B.D., Baillie, G.S., McCall, J.R., Passino, M.A., Schachtrup, C., Wallace, D.A., Dunlop, A.J., MacKenzie, K.F., Klussmann, E., Lynch, M.J., et al. (2007). p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway. J. Cell Biol. 177, 1119-1132. https://doi.org/10.1083/jcb.200701040
- Stupack, D.G., Teitz, T., Potter, M.D., Mikolon, D., Houghton, P.J., Kidd, V.J., Lahti, J.M., and Cheresh, D.A. (2006). Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 439, 95-99. https://doi.org/10.1038/nature04323
- Tabassum, A., Khwaja, F., and Djakiew, D. (2003). The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int. J. Cancer 105, 47-52. https://doi.org/10.1002/ijc.11038
- Teitz, T., Lahti, J.M., and Kidd, V.J. (2001). Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J. Mol. Med. 79, 428-436. https://doi.org/10.1007/s001090100233
- Thomas, A.A., Brennan, C.W., DeAngelis, L.M., and Omuro, A.M. (2014). Emerging therapies for glioblastoma. JAMA Neurol. 71, 1437-1444. https://doi.org/10.1001/jamaneurol.2014.1701
- Wang, L., Rahn, J.J., Lun, X., Sun, B., Kelly, J.J., Weiss, S., Robbins, S.M., Forsyth, P.A., and Senger, D.L. (2008). Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptor. PLoS Biol. 6, e289. https://doi.org/10.1371/journal.pbio.0060289
- Wilson, N.S., Dixit, V., and Ashkenazi, A. (2009). Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10, 348-355. https://doi.org/10.1038/ni.1714
- Winter, J., and Diederichs, S. (2011). MicroRNA biogenesis and cancer. Method Mol. Biol. 676, 3-22.
Cited by
- miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling vol.37, pp.1, 2018, https://doi.org/10.1186/s13046-018-0957-2
- MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-33696-1
- MicroRNA-296: a promising target in the pathogenesis of atherosclerosis? vol.24, pp.1, 2018, https://doi.org/10.1186/s10020-018-0012-y
- MicroRNA-296-5p promotes healing of diabetic wound by targeting sodium-glucose transporter 2 (SGLT2) vol.35, pp.2, 2018, https://doi.org/10.1002/dmrr.3104
- CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p vol.18, pp.1, 2019, https://doi.org/10.1186/s12943-019-0958-6
- Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma vol.23, pp.2, 2017, https://doi.org/10.3233/cbm-181258
- miR-296-5p inhibits IL-1β-induced apoptosis and cartilage degradation in human chondrocytes by directly targeting TGF-β1/CTGF/p38MAPK pathway vol.19, pp.12, 2017, https://doi.org/10.1080/15384101.2020.1750813
- Recent advances of the regulation roles of MicroRNA in glioblastoma vol.25, pp.7, 2017, https://doi.org/10.1007/s10147-020-01685-y
- miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets vol.117, pp.None, 2020, https://doi.org/10.1016/j.yexmp.2020.104550
- MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial–mesenchymal transition vol.25, pp.1, 2020, https://doi.org/10.1186/s11658-020-00240-x
- The Value of miR-296 and miR-517c in Evaluating the Prognosis of Patients with Glioma after Radiotherapy and Chemotherapy vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/6082458
- miR-296-5p Inhibits the Secretion of Pulmonary Surfactants in Pulmonary Epithelial Cells via the Downregulation of Wnt7b/ β -Catenin Signaling vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/4051504
- Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line vol.22, pp.3, 2017, https://doi.org/10.3390/ijms22031163
- Downregulation of miR-296-3p by highly pathogenic porcine reproductive and respiratory syndrome virus activates the IRF1/TNF-α signaling axis in porcine alveolar macrophages vol.166, pp.2, 2017, https://doi.org/10.1007/s00705-020-04921-y
- MicroRNA‑296‑5p inhibits cell proliferation by targeting HMGA1 in colorectal cancer vol.22, pp.2, 2017, https://doi.org/10.3892/etm.2021.10225
- SOCS proteins and their roles in the development of glioblastoma (Review) vol.23, pp.1, 2017, https://doi.org/10.3892/ol.2021.13123